These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22730199)

  • 1. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
    Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
    Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of amino acids functionalized α-GalCer analogues.
    Ma W; Bi J; Zhao C; Zhang Z; Liu T; Zhang G
    Bioorg Med Chem; 2020 Jan; 28(1):115141. PubMed ID: 31786009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
    Hung JT; Huang JR; Yu AL
    J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galacto-configured aminocyclitol phytoceramides are potent in vivo invariant natural killer T cell stimulators.
    Harrak Y; Barra CM; Delgado A; Castaño AR; Llebaria A
    J Am Chem Soc; 2011 Aug; 133(31):12079-84. PubMed ID: 21728320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
    Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
    Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.
    Fujio M; Wu D; Garcia-Navarro R; Ho DD; Tsuji M; Wong CH
    J Am Chem Soc; 2006 Jul; 128(28):9022-3. PubMed ID: 16834361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
    Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY
    Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4,5-cis unsaturated α-GalCer analogues distinctly lead to CD1d-mediated Th1-biased NKT cell responses.
    Cui Y; Li Z; Cheng Z; Xia C; Zhang Y
    Chem Res Toxicol; 2015 Jun; 28(6):1209-15. PubMed ID: 25955524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.
    Zhang W; Xia C; Nadas J; Chen W; Gu L; Wang PG
    Bioorg Med Chem; 2011 Apr; 19(8):2767-76. PubMed ID: 21439833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of C6''-modified α-C-GalCer analogues as mouse and human iNKT cell agonists.
    Guillaume J; Seki T; Decruy T; Venken K; Elewaut D; Tsuji M; Van Calenbergh S
    Org Biomol Chem; 2017 Mar; 15(10):2217-2225. PubMed ID: 28221388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo.
    Simkins HM; Hyde E; Farrand KJ; Ong ML; Degli-Esposti MA; Hermans IF; Ronchese F
    J Leukoc Biol; 2011 May; 89(5):753-62. PubMed ID: 21297009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands.
    Pauwels N; Aspeslagh S; Elewaut D; Van Calenbergh S
    Bioorg Med Chem; 2012 Dec; 20(24):7149-54. PubMed ID: 23122935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
    Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
    ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer.
    Lee T; Cho M; Ko SY; Youn HJ; Baek DJ; Cho WJ; Kang CY; Kim S
    J Med Chem; 2007 Feb; 50(3):585-9. PubMed ID: 17266209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
    Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
    J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
    Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
    Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.
    Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P
    J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.